Abstract:The regression discontinuity (RD) design is a quasi-experimental design that estimates the causal effects of a treatment by exploiting naturally occurring treatment rules. It can be applied in any context where a particular treatment or intervention is administered according to a pre-specified rule linked to a continuous variable. Such thresholds are common in primary care drug prescription where the RD design can be used to estimate the causal effect of medication in the general population. Such results can then be contrasted to those obtained from randomised controlled trials (RCTs) and inform prescription policy and guidelines based on a more realistic and less expensive context. In this paper we focus on statins, a class of cholesterol-lowering drugs, however, the methodology can be applied to many other drugs provided these are prescribed in accordance to pre-determined guidelines. NHS guidelines state that statins should be prescribed to patients with 10 year cardiovascular disease risk scores in excess of 20%. If we consider patients whose scores are close to this threshold we find that there is an element of random variation in both the risk score itself and its measurement. We can thus consider the threshold a randomising device assigning the prescription to units just above the threshold and withholds it from those just below. Thus we are effectively replicating the conditions of an RCT in the area around the threshold, removing or at least mitigating confounding. We frame the RD design in the language of conditional independence which clarifies the assumptions necessary to apply it to data, and which makes the links with instrumental variables clear. We also have context specific knowledge about the expected sizes of the effects of statin prescription and are thus able to incorporate this into Bayesian models by formulating informative priors on our causal parameters.

Bayesian analysis of longitudinal studies with treatment by indication

A Bayesian latent class approach to causal inference with longitudinal data

A Bayesian Framework for Causal Analysis of Recurrent Events with Timing Misalignment

Causal Inference using Multivariate Generalized Linear Mixed-Effects Models with Longitudinal Data

A Bayesian Phase II Proof-of-concept Design for Clinical Trials with Longitudinal Endpoints.

Bayesian inference for a principal stratum estimand to assess the treatment effect in a subgroup characterized by post-randomization events

Bayesian Approach for Design and Analysis of Medical Device Trials in the Era of Modern Clinical Studies

Bayesian regression discontinuity designs: Incorporating clinical knowledge in the causal analysis of primary care data

Bayesian Inference for Sequential Treatments Under Latent Sequential Ignorability

Estimating individualized treatment rules in longitudinal studies with covariate-driven observation times

Estimation of Causal Effects of Multiple Treatments in Observational Studies with a Binary Outcome

Bayesian Index Models for Heterogeneous Treatment Effects on a Binary Outcome

Bayesian analysis for pretest-posttest binary outcomes with adaptive significance levels

Deep Bayesian Estimation for Dynamic Treatment Regimes with a Long Follow-up Time

Causal inference in paired two-arm experimental studies under non-compliance with application to prognosis of myocardial infarction

A Bayesian method for safety signal detection in ongoing blinded randomised controlled trials

Bayesian leveraging of historical control data for a clinical trial with time-to-event endpoint

Bayesian Inference for Causal Effects in Randomized Experiments with Noncompliance

Bayesian Analysis of the Causal Effect in Clinical Trials with Ordered Compliance

Posterior predictive treatment assignment methods for causal inference in the context of time-varying treatments

A Bayesian nonparametric approach for evaluating the causal effect of treatment in randomized trials with semi-competing risks